Isabelle Thuret

6.0k total citations
113 papers, 2.4k citations indexed

About

Isabelle Thuret is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Isabelle Thuret has authored 113 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 58 papers in Hematology and 25 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Isabelle Thuret's work include Hemoglobinopathies and Related Disorders (66 papers), Iron Metabolism and Disorders (27 papers) and Hematopoietic Stem Cell Transplantation (17 papers). Isabelle Thuret is often cited by papers focused on Hemoglobinopathies and Related Disorders (66 papers), Iron Metabolism and Disorders (27 papers) and Hematopoietic Stem Cell Transplantation (17 papers). Isabelle Thuret collaborates with scholars based in France, United Kingdom and Italy. Isabelle Thuret's co-authors include Gérard Michel, Pierre Bordigoni, Hérvè Chambost, Catherine Badens, Guy Leverger, Yves Pérel, Thierry Leblanc, Éliane Gluckman, H Espérou-Bourdeau and Françoise Bernaudin and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Isabelle Thuret

108 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isabelle Thuret France	27	1.2k	726	596	511	359	113	2.4k
Naynesh Kamani United States	27	1.5k 1.3×	647 0.9×	581 1.0×	478 0.9×	248 0.7×	77	2.8k
Gérard Michel France	26	532 0.5×	180 0.2×	523 0.9×	565 1.1×	234 0.7×	77	1.8k
Claire Galambrun France	29	1.3k 1.1×	483 0.7×	489 0.8×	583 1.1×	312 0.9×	79	2.5k
Patrick J. Buckley United States	27	548 0.5×	187 0.3×	220 0.4×	355 0.7×	262 0.7×	93	2.2k
G. Cornu Belgium	21	873 0.8×	736 1.0×	424 0.7×	354 0.7×	244 0.7×	60	1.9k
Prakash Satwani United States	28	1.0k 0.9×	453 0.6×	448 0.8×	325 0.6×	271 0.8×	138	2.1k
Michael Grimley United States	22	869 0.8×	296 0.4×	286 0.5×	157 0.3×	189 0.5×	117	1.9k
Claudine Helg Switzerland	30	1.7k 1.5×	252 0.3×	254 0.4×	204 0.4×	226 0.6×	65	2.9k
Hanne Vibeke Marquart Denmark	22	582 0.5×	134 0.2×	437 0.7×	640 1.3×	228 0.6×	83	1.8k
Mitchell E. Horwitz United States	31	2.5k 2.1×	483 0.7×	257 0.4×	526 1.0×	726 2.0×	144	3.8k

Countries citing papers authored by Isabelle Thuret

Since Specialization

Citations

This map shows the geographic impact of Isabelle Thuret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Thuret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Thuret more than expected).

Fields of papers citing papers by Isabelle Thuret

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Thuret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Thuret. The network helps show where Isabelle Thuret may publish in the future.

Co-authorship network of co-authors of Isabelle Thuret

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Thuret. A scholar is included among the top collaborators of Isabelle Thuret based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Thuret. Isabelle Thuret is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olson, Timothy S., Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2025). Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent β-Thalassemia. Transplantation and Cellular Therapy. 31(2). S20–S20.

Marie, B. De Sainte, J. Séguier, Roch Giorgi, et al.. (2024). État de santé et qualité de vie des patients β-thalassémiques adultes à Marseille, France. La Revue de Médecine Interne. 45(4). 187–193. 1 indexed citations

Thuret, Isabelle, et al.. (2023). β‐Thalassemia in childhood: Current state of health in a high‐income country. British Journal of Haematology. 201(2). 334–342. 7 indexed citations

Walters, Mark C., Janet L. Kwiatkowski, John B. Porter, et al.. (2021). Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies. Transplantation and Cellular Therapy. 27(3). S112–S114. 1 indexed citations

Hongeng, Suradej, Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2021). Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion. Transplantation and Cellular Therapy. 27(3). S1–S1. 1 indexed citations

Thompson, Alexis A., Franco Locatelli, Evangelia Yannaki, et al.. (2021). Restoring Iron Homeostasis in Pts Who Achieved Transfusion Independence after Treatment with Betibeglogene Autotemcel Gene Therapy: Results from up to 7 Years of Follow-up. Blood. 138(Supplement 1). 573–573. 2 indexed citations

Thuret, Isabelle, Raoul Herbrecht, Florence Lachenal, et al.. (2021). Pregnancy outcome in women with transfused beta-thalassemia in France. Annals of Hematology. 101(2). 289–296. 6 indexed citations

Thompson, Alexis A., Janet L. Kwiatkowski, John B. Porter, et al.. (2020). Favorable Outcomes in Pediatric Patients in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia. Blood. 136(Supplement 1). 52–54. 7 indexed citations

Jacquier, Alexis, et al.. (2014). MRI monitoring of myocardial iron overload: Use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia. Diagnostic and Interventional Imaging. 95(11). 1065–1069. 6 indexed citations

10.

Ernst, Olivier, Isabelle Thuret, Philippe Petit, et al.. (2013). Iron overload of hematological origin: Validation of a screening procedure for cardiac overload by MRI in routine clinical practice. Diagnostic and Interventional Imaging. 94(6). 601–608. 7 indexed citations

11.

Merlin, Étienne, et al.. (2012). Long-term red blood cell exchange in children with sickle cell disease: Manual or automatic?. Transfusion and Apheresis Science. 48(2). 219–222. 27 indexed citations

12.

Urien, Saı̈k, Ghislaine Firtion, Suzanne T. Anderson, et al.. (2011). Lopinavir/ritonavir population pharmacokinetics in neonates and infants. British Journal of Clinical Pharmacology. 71(6). 956–960. 25 indexed citations

13.

Badens, Catherine, Philippe Joly, Isabelle Thuret, et al.. (2011). Variants in genetic modifiers of -thalassemia can help to predict the major or intermedia type of the disease. Haematologica. 96(11). 1712–1714. 59 indexed citations

14.

Barlogis, Vincent, Claude Lemarié, Claire Galambrun, et al.. (2010). Impact of Viable CD45 Cells Infused on Lymphocyte Subset Recovery after Unrelated Cord Blood Transplantation in Children. Biology of Blood and Marrow Transplantation. 17(1). 109–116. 5 indexed citations

15.

Bader‐Meunier, Brigitte, Guy Leverger, Gil Tchernia, et al.. (2005). Clinical and Laboratory Manifestations of Congenital Dyserythropoietic Anemia Type I in a Cohort of French Children. Journal of Pediatric Hematology/Oncology. 27(8). 416–419. 9 indexed citations

16.

Faye, Albert, Jean Paul Teglas, Marie‐Laure Chaix, et al.. (2002). Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants. The Pediatric Infectious Disease Journal. 21(6). 518–525. 38 indexed citations

17.

Giraud, P, Isabelle Thuret, D Reviron, et al.. (2000). Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience. Bone Marrow Transplantation. 25(1). 53–57. 37 indexed citations

18.

Thuret, Isabelle, Gérard Michel, Hérvè Chambost, et al.. (1999). Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency. AIDS. 13(1). 81–87. 20 indexed citations

19.

Michel, Gérard, Gèrard Socié, Isabelle Thuret, et al.. (1997). Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.. Journal of Clinical Oncology. 15(6). 2238–2246. 107 indexed citations

20.

Chambost, Hérvè, V. Gérolami, Philippe Halfon, et al.. (1995). Persistent hepatitis C virus RNA replication in haemophiliacs: role of co‐infection with human immunodeficiency virus. British Journal of Haematology. 91(3). 703–707. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact